TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3) Peptide
TAB3
Reactivity: Human
Host: Synthetic
BP, BI
-
- Target See all TAB3 products
- TAB3 (TGF-beta Activated Kinase 1/MAP3K7 Binding Protein 3 (TAB3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), BioImaging (BI)
- Characteristics
- MAP3K7IP3 peptide corresponds to 11 amino acids of MAP3K7IP3.
-
-
- Application Notes
- MAP3K7IP3 Peptide is used for blocking the activity of MAP3K7IP3 antibody . The MAP3K7IP3 antibody ships at 0.5 mg/mL and the MAP3K7IP3 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- MAP3K7IP3 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
You are here:
